Ocuphire Pharma Inc. Stock
Your prediction
Ocuphire Pharma Inc. Stock
The price for the Ocuphire Pharma Inc. stock decreased slightly today. Compared to yesterday there is a change of -€0.020 (-0.430%).
Our community identified positive and negative aspects for Ocuphire Pharma Inc. stock for the coming years. 2 users see the criterium "Worthwhile Investment for the next years" as a plus for the Ocuphire Pharma Inc. stock. On the other hand our users think that "Innovation" could be a problem in the future.
Pros and Cons of Ocuphire Pharma Inc. in the next few years
Pros
?
B****
?
C******** o* t** e**********
?
W********* I********* f** t** n*** y****
Cons
?
S********** s********
?
M***** P*******
?
G***** c******* t* c**********
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Ocuphire Pharma Inc. vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Ocuphire Pharma Inc. | -0.430% | 19.289% | 6.576% | 550.970% | 179.429% | -3.392% | - |
| NanoViricides Inc. | -0.580% | -5.464% | -13.500% | -14.356% | -6.989% | -17.619% | -77.080% |
| Immunic Inc. | -5.420% | -2.353% | -3.301% | 23.573% | 131.628% | -23.148% | -91.769% |
| Actinium Pharmaceuticals Inc. | 10.990% | -6.522% | -3.959% | -17.739% | -21.624% | -88.602% | -85.446% |
Comments
Ocuphire Pharma, Inc. (NASDAQ: OCUP) had its price target lowered by analysts at HC Wainwright from $20.00 to $18.00. They now have a "buy" rating on the stock.
Show more
Ratings data for OCUP provided by MarketBeat
Ocuphire Pharma, Inc. (NASDAQ: OCUP) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $20.00 price target on the stock.
Show more
Ratings data for OCUP provided by MarketBeat
Ocuphire Pharma, Inc. (NASDAQ: OCUP) had its price target lowered by analysts at Alliance Global Partners from $24.00 to $20.00. They now have a "buy" rating on the stock.
Show more
Ratings data for OCUP provided by MarketBeat
